Pharm Tech Minutes 2021.06.23
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Minutes
Welcome
- Participants
- Jose Costa Teixeira
- Stephane Spahni
- Michael Tan
- Juergen Brandstaetter
- Marc Robberecht
- Review and Approve Agenda
Medication lists
- Focus on the Sandbox which Jose has used for Belgium
- A patient has a treatment plan. This could initiated by the patient, but more often it could be a plan from a Care Provider.
- There could be multiple plans from different care providers.
- The diagram is actually treatment.
- Agreement in the group that there is a treatment, but difference is where to draw the line.
- The rules where to find the correct dosage will depend on the settings in the different countries.
- Rules to the period will differ per country. A current medication summary in NL& F means the last 6 months. In Switzerland it is what the patient is using now. Point is that we would like to define the differences.
- Within FHIR it makes it easier to map to another format from another country. The IHE profile would make the mapping much easier.
- The IPS is just a collection of medication statements.
- We should not use the same name as IPS. Suggestion to use medication view.
- Indication is mentioned on different levels. It also depends on the setting where to mention the indication.
- Action items for the F2F in September:
- generic guidelines to be written ( Stephane)
- Mapping to different country settings. Belgium, Switzerland, Netherlands, France, Austria. (all other members)